These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24657512)

  • 1. Impact of autoantibody glycosylation in autoimmune diseases.
    Goulabchand R; Vincent T; Batteux F; Eliaou JF; Guilpain P
    Autoimmun Rev; 2014 Jul; 13(7):742-50. PubMed ID: 24657512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimer formation in immunoglobulin preparations and speculations on the mechanism of action of intravenous immune globulin in autoimmune diseases.
    Tankersley DL
    Immunol Rev; 1994 Jun; 139():159-72. PubMed ID: 7927410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycosylation of autoantibodies in autoimmunes diseases].
    Goulabchand R; Batteux F; Guilpain P
    Rev Med Interne; 2013 Dec; 34(12):746-53. PubMed ID: 24139501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
    Seeling M; Brückner C; Nimmerjahn F
    Nat Rev Rheumatol; 2017 Oct; 13(10):621-630. PubMed ID: 28905852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review.
    Maverakis E; Kim K; Shimoda M; Gershwin ME; Patel F; Wilken R; Raychaudhuri S; Ruhaak LR; Lebrilla CB
    J Autoimmun; 2015 Feb; 57():1-13. PubMed ID: 25578468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):87-8. PubMed ID: 25546774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin Glycosylation - An Unexploited Potential for Immunomodulatory Strategies in Farm Animals.
    Zlatina K; Galuska SP
    Front Immunol; 2021; 12():753294. PubMed ID: 34733284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocytes--chief players and therapeutic targets in autoimmune diseases.
    Zouali M
    Front Biosci; 2008 May; 13():4852-61. PubMed ID: 18508550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies with enzymatic properties in human autoimmune diseases.
    Wootla B; Lacroix-Desmazes S; Warrington AE; Bieber AJ; Kaveri SV; Rodriguez M
    J Autoimmun; 2011 Sep; 37(2):144-50. PubMed ID: 21624820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
    Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
    J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.
    Albert H; Collin M; Dudziak D; Ravetch JV; Nimmerjahn F
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15005-9. PubMed ID: 18815375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pathogenic B-cell clones in antibody mediated autoimmune disorders.
    Wang J; Zhu X
    J Dermatol Sci; 2004 Dec; 36(3):141-8. PubMed ID: 15541635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody glycosylation in autoimmune diseases.
    Zhou X; Motta F; Selmi C; Ridgway WM; Gershwin ME; Zhang W
    Autoimmun Rev; 2021 May; 20(5):102804. PubMed ID: 33727152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies.
    Baudino L; Azeredo da Silveira S; Nakata M; Izui S
    Springer Semin Immunopathol; 2006 Oct; 28(2):175-84. PubMed ID: 16953439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.
    Foreman AL; Van de Water J; Gougeon ML; Gershwin ME
    Autoimmun Rev; 2007 Jun; 6(6):387-401. PubMed ID: 17537385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Structure, Isotypes, Targets, and Post-translational Modifications of Immunoglobulins and Their Role in Infection, Inflammation and Autoimmunity.
    Harb J; Wilson BS; Hermouet S
    Front Immunol; 2020; 11():1761. PubMed ID: 32849630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.